SCHEMBL9426466

SCHEMBL9426466

S=C(Nc1cnccc1-n1ccnc1)NC1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.51
▸ CD38 P28907 3/20 0.47
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ GAA P10253 2/20 0.44
▸ QPCT Q16769 1/20 0.44
▸ LMNA P02545 3/20 0.43
▸ MAPT P10636 2/20 0.43
▸ ALOX12 P18054 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9426543 0.82 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2GAALMNAMAPT
SCHEMBL9426354 0.76 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2GAALMNAMAPT
SCHEMBL9425866 0.76 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2GAALMNAMAPT
SCHEMBL9426037 0.75 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GAALMNAMAPT
SCHEMBL11473276 0.73 KMT2A (0.60) ALDH1A1CD38SMN1; SMN2MAPTMEN1
SCHEMBL9426020 0.73 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2GAALMNAMAPT
SCHEMBL9425868 0.72 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2GAALMNAMAPT
SCHEMBL9425921 0.72 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2GAALMNAALOX12
SCHEMBL16666104 0.72 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2GAALMNAMAPT
SCHEMBL9426269 0.71 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2GAALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5371086-A Circulatory disorders side effect reduction THE GREEN CROSS CORPORATION (JP) 1994-12-06 — — US disclosed
US-5262415-A FOR TREATING DISEASES OF THE CIRCULATORY SYSTEM THE GREEN CROSS CORPORATION (JP) 1993-11-16 — — US disclosed
EP-0503627-A1 Aminopyridine compounds THE GREEN CROSS CORPORATION (JP) 1992-09-16 — — EP disclosed
Send feedback